Drug to Prevent Preterm Births to Be Pulled From Market

  • 📰 WSJ
  • ⏱ Reading Time:
  • 3 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

The maker of Makena said it will stop selling the drug to prevent preterm births after a study couldn’t confirm the medicine worked

Covis Pharma, the maker of Makena, is planning the withdrawal after a study failed to confirm the drug works Makena was the only drug approved by the FDA to reduce the risk of preterm birth in women with a history of early deliveries.

Covis Pharma Group said it will stop selling its
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

just call it a supplement and nobody says diddly

How did it get approved in the first place?

Good, do aducanumab next.

Wtf are these things let out before we know this. Jesus f----- Christ

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in CA

Canada Canada Latest News, Canada Canada Headlines